Warning letter
Natural Technology, Inc.: warning letter of Dec 14, 2001
FDA warning letter UCM178415 · Dallas District Office
Key facts
| Reference number | UCM178415 |
|---|---|
| Company | Natural Technology, Inc. |
| Subject | Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated |
| Issue date | Dec 14, 2001 |
| Posted date | Dec 14, 2001 |
| Issuing office | Dallas District Office |
| Product type | Drugs |
| CFR sections cited | 211.188, 211, 211.80, 211.111, 211.150, 211.166, 211.192, 211.68(a), 211.84(d), 211.113(a), 211.165(a), 211.1 and 2 more |
| Country | 3 |
| Inspection city | Terrell |
| Inspection ZIP | 75160-6592 |
| Inspection start date | Sep 25, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: